Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics 1 Year Total Returns (Daily) : 24.19% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 24.19% |
| August 20, 2026 | 28.71% |
| August 19, 2026 | 29.84% |
| August 18, 2026 | 23.60% |
| August 17, 2026 | 31.35% |
| August 14, 2026 | 24.45% |
| August 13, 2026 | 20.86% |
| August 12, 2026 | 26.71% |
| August 11, 2026 | 26.13% |
| August 10, 2026 | 31.31% |
| August 07, 2026 | 32.90% |
| August 06, 2026 | 31.83% |
| August 05, 2026 | 26.98% |
| August 04, 2026 | 26.90% |
| August 03, 2026 | 29.74% |
| July 31, 2026 | 26.45% |
| July 30, 2026 | 26.73% |
| July 29, 2026 | 14.41% |
| July 28, 2026 | 17.61% |
| July 27, 2026 | 21.32% |
| July 24, 2026 | 20.36% |
| July 23, 2026 | 19.17% |
| July 22, 2026 | 22.52% |
| July 21, 2026 | 19.59% |
| July 20, 2026 | 32.14% |
| Date | Value |
|---|---|
| July 17, 2026 | 30.57% |
| July 16, 2026 | 29.52% |
| July 15, 2026 | 35.08% |
| July 14, 2026 | 29.43% |
| July 13, 2026 | 37.05% |
| July 10, 2026 | 38.46% |
| July 09, 2026 | 30.43% |
| July 08, 2026 | 35.64% |
| July 07, 2026 | 52.50% |
| July 06, 2026 | 41.18% |
| July 02, 2026 | 46.04% |
| July 01, 2026 | 44.29% |
| June 30, 2026 | 26.07% |
| June 29, 2026 | 44.44% |
| June 26, 2026 | 38.26% |
| June 25, 2026 | 38.41% |
| June 24, 2026 | 31.70% |
| June 23, 2026 | 38.89% |
| June 22, 2026 | 34.75% |
| June 18, 2026 | 33.56% |
| June 17, 2026 | 33.01% |
| June 16, 2026 | 20.19% |
| June 15, 2026 | 25.48% |
| June 12, 2026 | 19.63% |
| June 11, 2026 | 10.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -47.22% |
| Brainstorm Cell Therapeutics, Inc. | 55.31% |
| Summit Therapeutics, Inc. | -49.40% |
| Kezar Life Sciences, Inc. | 84.56% |
| Clene, Inc. | -19.10% |